Mirimus is engaged in the design, development and pioneering of new genome editing technologies to develop animal models that are crucial for the preclinical evaluation of new therapeutics
Mirimus is engaged in the design, development and pioneering of new genome editing technologies to develop animal models that are crucial for the preclinical evaluation of new therapeutics
Location:
760 Parkside Avenue, Suite 206, Brooklyn, NY 11226
Categories:
Synthetic Cells Tissues and Beyond
Founded in:
2010
Employee number:
<10
Annual revenue:
$1M